
|Videos|November 10, 2022
Update on adjuvant treatment of bladder cancer
Author(s)Urology Times staff
“The bar is high; we want to be curing these patients, not just delaying a recurrence of their cancer,” says Arlene O. Siefker-Radtke, MD.
Advertisement
In this video, Arlene O. Siefker-Radtke, MD, discusses recent developments in the adjuvant treatment of bladder cancer. Siefker-Radtke is a professor of Genitourinary Medical Oncology at the University of Texas MD Anderson Cancer Center in Houston. She was interviewed at the
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Urology Times
1
Why accurate CIS diagnosis matters in bladder cancer care
2
Darlifarnib plus cabozantinib shows encouraging antitumor activity in ccRCC
3
TULSA preserves penile length vs robotic prostatectomy in CAPTAIN trial
4
Joshua Halpern, MD, MS, on the clinical role of mail-in semen analysis
5












